Niosomes as vesicular carriers for delivery of proteins and biologicals
Keywords:
Niosomes, Proteins, Biologicals, Vaccines, Oral deliveryAbstract
Over the past several years, treatment of infectious diseases and immunization has undergone a paradigm shift. Stemming from the nanobiotechnology research, not only a large number of disease-specific biologicals have been developed, but also enormous efforts have been made to effectively deliver these biologicals. Niosomes are vesicular systems prepared from selfassembly of hydrated non-ionic surfactants. Opinions of the usefulness of niosomes in delivery of proteins and biologicals range from unsubstantiated optimism to undeserved pessimism. This article reviews the current deepening and widening of interest of niosomes in many scientific disciplines, and their application in medicine particularly for the delivery of proteins (insulin, cyclosporine, bacitracin, trypsin), vaccines and antigens (bovine serum albumin, antigen tetanus toxoid, haemagglutinin). This article also presents an overview of techniques of noisome preparation, characterization of niosomes and their applications.
References
Juliano RL. Microparticulate drug carriers:
liposomes, microspheres and
cells.In:Robinson JR, Lee VHL, editors.
Controlled drug delivery. 2nd ed. New York:
Marcel Dekker, Inc.; 2005. p. 555-80.
Rawat M, Singh D, Saraf S, Saraf S.
Nanocarriers: promising vehicles for
bioactive drugs. Biol Pharm Bull
;29:1790-8.
Al-Tahami K, Singh J. Smart polymer based
delivery systems for peptides and proteins.
Recent Pat Drug Deliv Formul 2007;1:65-71.
Chien YW. Novel drug delivery systems. 2nd
ed. New York: Marcel Dekker, Inc.; 2007. p.
-47.
Powell MF. Drug delivery issues in vaccine
development. Pharm Res 1996;13:1777–
Lasic DD. On the thermodynamic stability of
liposomes. J Colloid Interface Sci
;140:302-304
Biswal S, Murthy PN, Sahu J, Sahoo P,
Amir F. Vesicles of Non-ionic Surfactants
(Niosomes) and Drug Delivery Potential.Int J
Pharm Sci Nanotechnology.2008;1(1):1-10
Agarwal S, Bakshi V, Vitta P , Raghuram
AP, Pandey S, Udupa N. Effect of
Cholesterol Content and Surfactant HLB on
Vesicle Properties of Niosomes.Int J Ph Sci
;66(1):121-123
Uchegbu FI, Vyas PS. Non-ionic surfactant
based vesicles (niosomes) in drug delivery.Int
J Pharm 1998;172:33-70
Girigoswami A, Das S, De S. Fluorescence
and dynamic light scattering studies of
niosomes-membrane mimetic systems.
Spectrochimica Acta PartA. 2006;64:859-866
Terzano C, Allegra L, Alhaique F, Marianecci
C, Carafa M. Non-Phospholipid vesicles for
pulmonary glucocorticoid delivery.Eur J
Pharm Biopharm 2005;59(1):57-62
Pardakhty A, Varshosaz J, Rouholamini A. In
vitro study of polyoxyethylene alkyl ether
niosomes for delivery of insulin .Int J Pharm
;328(2):130-141
Manosaroi A, Khanrin P, Werner RG, Gotz F,
Manosaroi W, Manosroi J. Entrapment
enhancement of peptide drugs in niosomes.J
Microencapsul 2010;27(3):272-280
Rentel CO, Boustra JA, Naisbett B, Junginger
HE. Niosomes as a novel peroral vaccine
delivery system.Int J Pharm 1999;186(2):161-
Ning M, Guo Y, Pan H, Yu H, Gu Z.
Niosomes with sorbitan monoester as a
carrier for vaginal delivery of insulin:studies
in rats. Drug Deliv 2005;12(6):399-407
Muller JM, Lelievre V, Becq-Giraudon
L,Meuiner AC. VIP as a cell-growth and
differentiation neuromodulator role in
neurodevelopment.Mol Neurobiol
;10:115-134
Dufes C, Gaillard F,Uchegbu IF, Schatzlein
AG, Olivier JC, Muller JM. Glucose –
targeted niosomes deliver vasoactive
intestinal peptide (VIP) to the brain .Int J
Pharm 2004;285(1):77-85
Niemec SM, Hu Z, Ramachandran C,
Wallach DFH, Weiner N. The effect of
dosing volume on the disposition of
cyclosporine A in hairless mouse skin after
topical application of non-ionic liposomal
formulation .An in vitro diffusion study .STP
Pharm Sci 1994;2:145-149
Niemac SM, Ramachandran C, Weiner N.
Influence of non-ionic liposomal composition
on topical delivery of peptide drugs into
pilosebaceous units: an in-vivo study using
hamster ear model. Pharm Res
;12:1184–1188
Reddy DN, Udupa N. Formulation and
evaluation of oral and transdermal
preperations of flurbiprofen and piroxicam
incorporated with different carriers. Drug Dev
Ind Pharm 1993;19:843-852
Schreier H, Bouwstra J. Liposomes and
niosomes as topical drug carriers-dermal and
transdermal drug-delivery.J Control Rel
;30:1–15.
Junginger HE, Hofland HEJ, Bouwstra JA.
Liposomes and niosomes :interactions with
human skin .Cosmet Toilet 1991;106:45-50
Cevc G. Transferosomes, liposomes and other
lipid suspensions on the skin:permeation
enhancement ,vesicle penetration and
transdermal drug delivery .Crit Rev
Therapeut Drug Carr Syst 1996;13:257-388
Gopinath D, Ravi D, Rao BR, Apte SS,
Renuka D, Rambhau D. Ascorbyl palmitate
vesicles (Aspasomes): formation
,characterization and application.Int J Pharm
;271:95-113
Huang Y ,Chen J, Chen X, Gao J, Liang W.
PEGylated synthetic surfactant vesicles
(Niosomes):novel carriers for
oligonucleotides. J Mater Sci Mater Med
;19(2):607-614
Cortesi R, Esposito E, Corradini F,Sivieri E,
Drechsler M, Rossi A, Scatturin A, Menegatti
E. Non –phospholipid vesicles as carriers for
peptides and proteins :production,
characterization and stability studies. Int J
Pharm 2007;339(1-2):52-60
Hilgers LA, Zigterman GJWJ, Snippe H.
Immunomodulating properties of amphiphilic
agents. In:Kammuller, M.E., Bioksma, N.,
Sienen, W. (Eds.), Autoimmunity and
Toxicology. Elsevier, Amsterdam. 1989. p
.294–306
Brewer JM, Roberts CW, Conacher M,
McColl J, Blarney BA, Alexander J. An
adjuvant formulation that preferentially
induces T-helper cell type 1 cytokine and
CD8+Cytotoxic responses is associated with
up-regulation of IL-12 and suppression of IL-
production.Vaccine Res 1996;5:77-89
Brewer JM, Alexander J. The adjuvant
activity of non-ionic surfactant vesicles
(niosomes) on the BALB/c humoral response
to bovine serum albumin.Immunology
;75:570-575
Walker W, Brewer JM, Alexander J. Lipid
vesicle-entrapped influenza A antigen
modulates the influenza A-Specific human
antibody response in immune reconstituted
SCID-human mice. Eur J Immuol
;26:1664-1667
Yoshioka T, Florence AT. Vesicle
(niosome)-in-water-in-oil (v:w:o) emulsionsan in-vitro study. Int J Pharm 1994;108:117–
Yoshioka T, Skalko N, Gursel M, Gregoriadis
G, Florence AT. A non-ionic surfactant
vesicle-in-water-in-oil(v/w/o) systempotential uses in drug and vaccine delivery.J
Drug Target 1995;2:533-539
Murdan S, Gregoriadis G, Florence AT.
Sorbitan monostearate/polysorbate 20
organogels containing niosomes: a delivery
vehicle for antigens? Eur J Pharm Sci
;8(3):177-186
Jain S, Vyas SP. Mannosylated niosomes as
adjuvant – carrier system for oral mucosal
immunization . J Liposome Res
;16(4):331-345
Erdogan S, Ozer AY, Erean MT, Erylmaz M,
Hincal AA.In-vivo studies on iopromide
radiopaque niosomes.STP Pharma Sci
;6:87-93
